Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1652
  • Home
  • Print this page
  • Email this page

    Article Cited by others

SYMPOSIUM

Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration

Gopal Lekha, Sharma Tarun

Year : 2007| Volume: 55| Issue : 6 | Page no: 431-435

   This article has been cited by
 
1 Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells
Siva P. Kambhampati,Manoj K. Mishra,Panagiotis Mastorakos,Yumin Oh,Gerard A. Lutty,Rangaramanujam M. Kannan
European Journal of Pharmaceutics and Biopharmaceutics. 2015;
[Pubmed]  [Google Scholar] [DOI]
2 Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration
Anjali Hirani,Aditya Grover,Yong W. Lee,Yashwant Pathak,Vijaykumar Sutariya
Pharmaceutical Development and Technology. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Drug safety evaluation of intravitreal triamcinolone acetonide
Daniele Veritti, Andrea Di Giulio, Valentina Sarao, Paolo Lanzetta
Expert Opinion on Drug Safety. 2011; : 1
[HTML Full text]  [Google Scholar] [DOI]
4 Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema
Taygan Yilmaz, Miguel Cordero-Coma, Thomas J Federici
Expert Opinion on Drug Metabolism & Toxicology. 2011; : 1
[HTML Full text]  [Google Scholar] [DOI]
5 Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment
Marieke Veurink, Cinzia Stella, Cyrus Tabatabay, Constantin J. Pournaras, Robert Gurny
European Journal of Pharmaceutics and Biopharmaceutics. 2011; 78(2): 271
[HTML Full text]  [Google Scholar] [DOI]
6 Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone for Therapy-Resistant Exudative Age-Related Macular Degeneration
Yong Tao,Jost B. Jonas
Journal of Ocular Pharmacology and Therapeutics. 2010; 26(2): 207
[Pubmed]  [Google Scholar] [DOI]
7 Intravitreal triamcinolone
Tao, Y., Jonas, J.B.
Ophthalmologica. 2010; 225(1): 1-20
[Pubmed]  [Google Scholar]
8 Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration
Tao, Y., Jonas, J.B.
Journal of Ocular Pharmacology and Therapeutics. 2010; 26(2): 207-211
[Pubmed]  [Google Scholar]
9 Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Criswell, M.H. and Hu, W.Z. and Steffens, T.J. and Li, R. and Margaron, P.
Archives of Ophthalmology. 2008; 126(7): 946
[Pubmed]  [Google Scholar]

 

Read this article